![](/images/graphics-bg.png)
Poor Outcomes in Hepatic Amyloidosis: A Report of 2 Cases
Joint Authors
Yim, Brandom
Kertowidjojo, Elizabeth
Zhang, Yue
Patel, Pruthvi
Source
Case Reports in Oncological Medicine
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-09-28
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Hepatic amyloidosis is a rare disease entity that results from insoluble amyloid protein deposition in the liver.
The disease often presents with vague, nonspecific clinical features.
Currently, there is little literature describing treatment outcomes for biopsy-proven hepatic amyloidosis and current treatment guidelines recommend that patients enroll in a clinical trial due to insufficient evidence to suggest an optimal treatment regimen.
Here, we present two cases of hepatic amyloidosis at an academic medical center and describe their presentation, treatment, and outcomes.
These cases highlight the poor outcomes and difficult management of hepatic amyloidosis.
Further understanding and investigation of this rare disease are warranted.
American Psychological Association (APA)
Yim, Brandom& Kertowidjojo, Elizabeth& Zhang, Yue& Patel, Pruthvi. 2016. Poor Outcomes in Hepatic Amyloidosis: A Report of 2 Cases. Case Reports in Oncological Medicine،Vol. 2016, no. 2016, pp.1-5.
https://search.emarefa.net/detail/BIM-1101715
Modern Language Association (MLA)
Yim, Brandom…[et al.]. Poor Outcomes in Hepatic Amyloidosis: A Report of 2 Cases. Case Reports in Oncological Medicine No. 2016 (2016), pp.1-5.
https://search.emarefa.net/detail/BIM-1101715
American Medical Association (AMA)
Yim, Brandom& Kertowidjojo, Elizabeth& Zhang, Yue& Patel, Pruthvi. Poor Outcomes in Hepatic Amyloidosis: A Report of 2 Cases. Case Reports in Oncological Medicine. 2016. Vol. 2016, no. 2016, pp.1-5.
https://search.emarefa.net/detail/BIM-1101715
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1101715